Last update:

Medications news

Medications

Anti-platelet drug can slow metastasis in aggressive cancers, research shows

Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new research shows that a drug in clinical trials may help stop the spread of cancer before it reaches ...

Medications

Telling people to use antibiotics responsibly isn't enough. What will work instead?

Antimicrobial resistance is projected to cause up to 10 million deaths each year by 2050, making it one of the most pressing global health challenges of this century. In 2021, an estimated 4.71 million deaths were associated ...

Medications

GLP-1RAs shown to reduce risk of cardiovascular death

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials ...

Medications

Experimental drug repairs DNA damage caused by common diseases

Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory disease or other conditions.

Medications

Pain med side effects may be masquerading as heart failure

Clinicians may fail to recognize common side effects of drugs like gabapentin—which are frequently prescribed for nerve pain—leading them to prescribe unnecessary medications that cause yet more side effects. This phenomenon, ...

Medications

How anti-epilepsy drugs alter a key brain protein structure

A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators established for the first time how certain drugs used to treat epilepsy affect their target.

Medications

Study finds people on colchicine need less joint replacement

Gout is the most common form of inflammatory arthritis, with a worldwide prevalence of approximately 4%. The accumulation of monosodium urate crystals in gout leads to the clinical manifestations of the disease and, if left ...

Medications

EU approves contentious Alzheimer's medication

The European Union on Thursday approved the highly contentious Alzheimer's medication Kisunla under strict conditions, with the drug's effectiveness hotly debated by the medical community.

Medications

Emergency calls for pediatric opioid exposure on the rise

Years after the opioid epidemic began in the mid-1990s, emergency medical services are seeing increases in emergency calls for pre-teens and adolescents, according to research presented during the American Academy of Pediatrics ...

Medications

Study explains loss of efficacy of common type 2 diabetes drug

Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the market in the early 1950s. However, although they are one of the most common drugs for this condition, ...

Medications

White House autism-Tylenol link leads to confusion

President Donald Trump's announcement advising Americans against taking acetaminophen during pregnancy to avoid the chance of autism was met with pushback from some lawmakers, including a key GOP health figure.

Medications

Trump administration to link Tylenol to autism

On Sept. 22, Trump administration officials plan to link the active ingredient in Tylenol to autism, the Washington Post reported, citing unnamed people familiar with the matter.